Category Archives: Public Policy

Latest From Public Policy

The Pivotal Role the Public Market Plays in Financing R&D

KennethMoch-Chimerix

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle – the daily challenge of running a growing company combined with the roadblocks intrinsic to groundbreaking scientific advancement. Innovative companies must overcome capital formation barriers in order to fund their next generation R&D.  The financing challenges that emerging biotechs face are unique, but we have the potential to save lives and treat patients in desperate need of hope. Today, I Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Joins Alliance for Fair Trade with India

shutterstock_26191726

BIO recently joined the Alliance for Fair Trade with India along with the U.S. Chamber of Commerce, the National Association of Manufacturers, Solar Energy Industries Association, and others. The new Alliance website states: Over the last year, policymakers and courts in India have engaged in a persistent pattern of discrimination that is hurting a wide range of manufacturing and services industries and jobs in the United States. India has recently mandated domestic content rules that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

President Obama Talks Climate Change: “We need to act”

earth day jump optional

On the steps of Georgetown University Tuesday, President Obama announced his multi-step plan to fight climate change and called the American people to action. The President began his speech by citing facts and examples of climate change that have already been witnessed across this nation. In 2012 alone, climate and weather disasters, which stem from our warming planet, cost the American economy more than $100 billion. Left unmitigated, global warming will continue to cause increasingly Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

MERS, Patents, and Material Transfer Agreements: What WHO Didn’t Know

Photo by NIAID_Flickr

The outbreak of the Middle East Respiratory Syndrome (MERS-CoV), a SARS like virus has lead to some strong anti-IP statements in Geneva.  A recent article titled “Finding a Fall Guy for Middle East Respiratory Syndrome” in IPWatchdog provides context from multiple news sources and concludes: “An independent review of the claims that patents and the [Material Transfer Agreements] are hindering international MERS-COV research appeared in a May 28, 2013 story in Science Insider. Here’s the lead: Are Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Myriad Supreme Court Decision: BIO’s Statement

4973532326_6c75ba32ba copy

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on  the U.S. Supreme Court’s decision regarding Myriad Genetics’ patent claims on isolated DNA molecules: “The Supreme Court today summarily ruled that so-called cDNA remains eligible for patenting.  cDNA is the commercially most important form of DNA used in biotechnology.  Today’s decision offers urgently-needed Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , ,